Global Pericardial Disease Market, Size, Share, Analysis Report & Forecast to 2026

The global pericardial disease market is anticipated to grow at a CAGR of around 5.5% during the forecast period. Pericardial disease is a medical condition that involves swelling and irritation in the pericardium. The pericardium is a two-layer sac that separates the heart from surrounding structures and protects it from vibration and external shocks. The patient with heart surgeries and other related surgeries become more vulnerable to such diseases. The rising number of geriatric population and prevalence of cardiovascular diseases is the major factor for the growth of the market. According to the American College of Cardiology report, in 2019, CVD was the underlying cause of 9.6 million deaths among men and 8.9 million mortalities among women, around a third of all mortalities across the globe. Over 6 million of this mortality occurred in people between the ages of 30-70. The highest number of CVD deaths occurred in China, followed by India, Russia, the US and Indonesia. Additionally, prevalent cases of total CVD nearly doubled from 271 million in 1990 to 523 million in 2019, and the number of CVD mortalities steadily increased from 12.1 million in 1990, reaching 18.6 million in 2019.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/pericardial-disease-market

The global pericardial disease market is segmented based on type, diagnosis method, and treatment approach. Based on type the market is sub-segmented into acute pericarditis, chronic pericarditis, and recurrent pericarditis. Based on the diagnosis method, the market is segregated into chest X-Ray, cardiac MRI, cardiac CT scan, echocardiography, electrocardiography, and others (blood test). Whereas, on the basis of treatment, the market is bifurcated into NSAIDS drugs and pericardiectomy. The NSAIDS drug segment is anticipated to grow with significant market share during the forecast period. Nonsteroidal anti-inflammatory drugs are the first-line treatment for pericardial effusion caused by inflammation. The significant use of these drugs during the pericardial treatment will create its demand in the market, which will further drive the market growth.

A Full Report of Global Pericardial Disease Market is Available at: https://www.omrglobal.com/industry-reports/pericardial-disease-market

Geographically, the global pericardial disease market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Asia-Pacific is projected to witness the fastest growth in the global pericardial disease market due to the rapid development of the healthcare industry and the rising cases of diseases due to sedentary lifestyles.

Global Pericardial Disease Market– Segmentation
By Type
Acute Pericarditis
Chronic Pericarditis
Recurrent Pericarditis
By Diagnosis Method
Chest X-Ray
Cardiac MRI
Cardiac CT scan
Echocardiography
Electrocardiography
Others (Blood Test)
By Treatment Approach
Non-steroidal Anti-Inflammatory Agents (NSAIDS) Drugs
Pericardiectomy

Global Pericardial Disease Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Abbott Laboratories
AliveCor, Inc.
AstraZeneca PLC
Bayer AG
CardioComm Solutions, Inc.
Coloplast Corp.
CryoLife, Inc.
Edwards Lifesciences Corp.
General Electric Co.
Integra LifeSciences Corp.
Kiniksa Pharmaceuticals, Ltd.
LivaNova PLC
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
VectraCor Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pericardial-disease-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com 
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.